Vitrolife Ownership

VITR Stock  SEK 167.10  5.80  3.35%   
Vitrolife maintains a total of 135.45 Million outstanding shares. Vitrolife AB maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Some institutional investors establish a significant position in stocks such as Vitrolife in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Vitrolife, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vitrolife AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Vitrolife Stock Ownership Analysis

About 32.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.61. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vitrolife AB last dividend was issued on the 28th of April 2022. The entity had 5:1 split on the 17th of May 2018. Vitrolife AB , a medical device company, develops, produces, and markets products for assisted reproduction. Vitrolife AB was founded in 1981 and is headquartered in Gothenburg, Sweden. Vitrolife operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 415 people. For more information please call Thomas MSc at 46 3 17 21 80 00 or visit https://www.vitrolife.com.

Vitrolife Outstanding Bonds

Vitrolife issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vitrolife AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vitrolife bonds can be classified according to their maturity, which is the date when Vitrolife AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vitrolife Stock Analysis

When running Vitrolife's price analysis, check to measure Vitrolife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitrolife is operating at the current time. Most of Vitrolife's value examination focuses on studying past and present price action to predict the probability of Vitrolife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitrolife's price. Additionally, you may evaluate how the addition of Vitrolife to your portfolios can decrease your overall portfolio volatility.